Insider Transactions in Q4 2023 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,163
-4.25%
|
$25,304
$8.83 P/Share
|
|
Dec 06
2023
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,177
-4.02%
|
$15,239
$7.55 P/Share
|
|
Dec 01
2023
|
Anne Marie Bickmore COO and Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,114
-6.06%
|
$28,798
$7.45 P/Share
|
|
Dec 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-1.71%
|
$20,447
$7.45 P/Share
|
|
Dec 01
2023
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,478
-0.94%
|
$59,346
$7.45 P/Share
|
|
Dec 01
2023
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,161
-5.3%
|
$29,127
$7.45 P/Share
|
|
Dec 01
2023
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,427
-7.11%
|
$23,989
$7.45 P/Share
|
|
Dec 01
2023
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,838
-4.98%
|
$19,866
$7.45 P/Share
|
|
Dec 01
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,118
-6.02%
|
$98,826
$7.45 P/Share
|
|
Nov 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,196
-1.5%
|
$9,568
$8.25 P/Share
|
|
Oct 16
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,161
-1.44%
|
$9,288
$8.33 P/Share
|
|
Oct 05
2023
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+29.33%
|
-
|